Form D Explorer

Inspect source fieldsReport a record issue

Form D — X4 Pharmaceuticals, Inc

0001470831-25-000145 · filed Aug 25, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$84,999,985
Reported amount sold
$84,999,985
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
X4 Pharmaceuticals, Inc
CIK
1501697
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
61 NORTH BEACON STREET
BOSTON, Massachusetts 02134
Phone
857-529-8300

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗